- Home
- CIIT vs NMTC Comparison
CIIT vs NMTC Comparison
Compare CIIT & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIIT
- NMTC
- Stock Information
- Founded
- CIIT N/A
- NMTC 2009
- Country
- CIIT Hong Kong
- NMTC United States
- Employees
- CIIT N/A
- NMTC N/A
- Industry
- CIIT
- NMTC Medical/Dental Instruments
- Sector
- CIIT
- NMTC Health Care
- Exchange
- CIIT NYSE
- NMTC Nasdaq
- Market Cap
- CIIT 34.6M
- NMTC 30.9M
- IPO Year
- CIIT N/A
- NMTC N/A
- Fundamental
- Price
- CIIT $2.18
- NMTC $0.69
- Analyst Decision
- CIIT
- NMTC Strong Buy
- Analyst Count
- CIIT 0
- NMTC 1
- Target Price
- CIIT N/A
- NMTC $1.45
- AVG Volume (30 Days)
- CIIT 118.8K
- NMTC 191.1K
- Earning Date
- CIIT 06-09-2025
- NMTC 08-13-2025
- Dividend Yield
- CIIT N/A
- NMTC N/A
- EPS Growth
- CIIT N/A
- NMTC N/A
- EPS
- CIIT N/A
- NMTC N/A
- Revenue
- CIIT $9,464,501.00
- NMTC $5,758,777.00
- Revenue This Year
- CIIT N/A
- NMTC $141.04
- Revenue Next Year
- CIIT N/A
- NMTC $38.86
- P/E Ratio
- CIIT N/A
- NMTC N/A
- Revenue Growth
- CIIT 51.52
- NMTC 54.53
- 52 Week Low
- CIIT $1.30
- NMTC $0.40
- 52 Week High
- CIIT $5.38
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- CIIT N/A
- NMTC 62.90
- Support Level
- CIIT N/A
- NMTC $0.56
- Resistance Level
- CIIT N/A
- NMTC $0.71
- Average True Range (ATR)
- CIIT 0.00
- NMTC 0.05
- MACD
- CIIT 0.00
- NMTC 0.01
- Stochastic Oscillator
- CIIT 0.00
- NMTC 86.48
About CIIT TIANCI INTERNATIONAL INC
Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.